Literature DB >> 12375271

Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells.

Enzo Nisoli1, Laura Regianini, Luca Briscini, Alessandra Bulbarelli, Luca Busetto, Alessandra Coin, Giuliano Enzi, Michele O Carruba.   

Abstract

Multiple symmetric lipomatosis (MSL) is an inherited disorder in which enlarging and unencapsulated lipomas symmetrically develop in the subcutaneous tissue of the neck, shoulders, mammary, and truncal regions. In some cases, it is associated with mitochondrial DNA abnormalities. The pathogenesis of MSL is completely unknown, although the fat deposits may be due to a neoplastic-like proliferation of functionally defective brown adipocytes. It has recently been demonstrated that the beta(3)-adrenergic receptor is the functionally relevant adrenergic receptor subtype in brown adipocytes and that its stimulation by noradrenaline (NA) modulates the expression of genes, such as uncoupling protein (UCP)-1 and inducible nitric oxide synthase (iNOS), involved in fat cell proliferation and differentiation. Furthermore, Trp64Arg mutation of the beta(3)-adrenoceptor has been implicated in lower NA activity in adipose tissues. The aim of this study was to investigate the molecular and functional characteristics of MSL adipocytes and to analyse the effects of nitric oxide (NO) on the proliferation/differentiation of MSL adipocytes in culture, and the relevance of putative noradrenergic deficit in the development of lipomas in MSL patients. Cultured MSL adipocytes were able to synthesize UCP-1 (the selective marker of brown adipocytes), but unlike that of normally functioning brown fat cells, the expression of the UCP-1 gene was not significantly induced by NA. NA is also defective in inducing iNOS gene expression, thus leading to reduced NO production and a consequent reduction in the anti-proliferative, adipogenic (mitochondrial biogenesis) effects of NA on MSL cells. Furthermore, the transcriptional peroxisome proliferator-activated receptor gamma co-activator-1 (PGC-1), which plays a key role in the sympathetic-stimulated mitochondrial biogenesis of brown adipocytes, is expressed but not induced by NA in MSL cells, as it is in brown adipocytes. The study did not find any association between beta(3)-adrenoceptor gene polymorphism and noradrenergic signalling defects in MSL subjects with or without mitochondrial DNA mutations. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375271     DOI: 10.1002/path.1212

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Madelung disease.

Authors:  Fang-ying Lin; Tsung-Lin Yang
Journal:  CMAJ       Date:  2012-06-25       Impact factor: 8.262

Review 2.  Rare adipose disorders (RADs) masquerading as obesity.

Authors:  Karen L Herbst
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

3.  Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment?

Authors:  Zeitler Heike; Ulrich-Merzenich Gudrun; Richter Dirk Frank; Hans Vetter; Peter Walger
Journal:  Obes Surg       Date:  2008-01-04       Impact factor: 4.129

4.  A case of Madelung's disease presenting with obstructive sleep apnea.

Authors:  Charnsiri Segsarnviriya; Naricha Chirakalwasan
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

5.  State of diagnostic quandary solved by modern technology: a rare case of Madelung's disease.

Authors:  Htoo Kyaw; Michael Grillo; Aung Naing Lin; David A Kapp
Journal:  BMJ Case Rep       Date:  2016-02-05

6.  Multiple benign symmetric lipomatosis--a differential diagnosis of obesity. Is there a rationale for fibrate treatment?

Authors:  Heike Zeitler; Gudrun Ulrich-Merzenich; Dirk Frank Richter; Hans Vetter; Peter Walger
Journal:  Obes Surg       Date:  2008-06-05       Impact factor: 4.129

7.  PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors.

Authors:  Joan Sanchez-Gurmaches; Chien-Min Hung; Cynthia A Sparks; Yuefeng Tang; Huawei Li; David A Guertin
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

8.  Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report.

Authors:  Maddalena Borriello; Alessandro Lucidi; Arnaldo Carbone; Vito Iannone; Gabriella Ferrandina
Journal:  Diagn Pathol       Date:  2012-09-01       Impact factor: 2.644

9.  Case report of comorbid alcohol-induced psychotic disorder and Madelung's disease.

Authors:  Zhenxiao Sun; Huanjun Li
Journal:  Shanghai Arch Psychiatry       Date:  2014-06

10.  Madelung disease.

Authors:  Bogna Zielińska-Kaźmierska; Michał Lewicki; Bogusława Manowska
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.